Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Deutsche Boerse AG  >  Nestlé    NESR   CH0038863350


News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Nestlé Enters Exclusive Talks to Sell Skin-Health Business--3rd Update

share with twitter share with LinkedIn share with facebook
share via e-mail
05/16/2019 | 05:12am EDT

By Brian Blackstone

ZURICH -- Nestle SA has entered exclusive talks to sell its skin-health business to private-equity firm EQT and the Abu Dhabi Investment Authority for 10.2 billion Swiss francs ($10.1 billion), its latest move to reshape its sprawling portfolio and revive sluggish growth.

The Swiss consumer goods giant said in September it was exploring options for the unit as part of a broader effort by Chief Executive Mark Schneider to reinvigorate Nestlé's portfolio and focus more on coffee, pet care and consumer health.

Nestle said Thursday it expected to close the sale of the skin-health business, which includes face-care products Cetaphil and Proactiv, in the second half of the year, at which point it would update investors on what it planned to do with the proceeds and its future capital structure.

The division generated net sales of 2.8 billion Swiss francs in 2018.

Analysts at Vontobel Research said the price tag was at the high end of its estimates. "In our model, we carried a price of 7 billion Swiss francs. However, we didn't rule out a price tag of up to 10 billion Swiss francs," they said.

Nestlé established its skin-health unit in 2014 after taking full control of Galderma, which added acne and skin-cancer treatment to its portfolio. Nestlé said at the time it wanted to take a more holistic approach to health than "mere nutrition" and bolstered the unit with several acquisitions including a $1.4 billion deal for skin-care products from Valeant Pharmaceuticals Inc. But as sales growth slowed, investors questioned how the unit fits into Nestlé's broader business.

Nestle is being advised on the deal by Credit Suisse and Evercore.

Founded in 1994 with the backing of Sweden's prominent Wallenberg family, EQT has grown into one of Europe's largest buyout firms with about EUR40 billion ($44.8 billion) in assets under management, according to its web site.

The EQT-led consortium's pursuit of the business and hefty price it's paying comes as private-equity firms in general are under pressure to invest the sector's record amount of cash that the industry has raised in recent years from investors.

Carved-out businesses from a larger company are particularly attractive to private equity firms because they are often large, allowing the buyout firms to deploy big amounts of cash quickly. As non-core to the parent company, these types of divisions offer an opportunity for the buyer to grow the businesses by employing a dedicated management team and devoting resources that the units might otherwise not be getting as part of a larger entity.

Similar deals in Europe include KKR & Co.'s EUR6.83 billion deal in 2017 to acquire Unilever PLC's margarine-and-spreads business and the EUR10.1 billion acquisition of the specialty chemicals business of Dutch paints giant Akzo Nobel NV last year.

Thursday's step underscored Nestlé's prodding approach to revamping its product mix that includes Purina pet food and Lean Cuisine frozen meals and generates annual sales of around 91 billion Swiss francs. Faced with pressure from activist investors two years ago, Nestle said it would focus its capital spending on high-growth areas such coffee, pet care, and infant nutrition in a bid to combat sluggish sales in a fast-changing consumer environment.

Its approach has paid off. Last month, Nestle reported annual comparable sales growth of 3.4%, topping analyst expectations. Its share price is up 28% in the last year. Nestle shares were little changed late morning Thursday.

Last year, Nestlé sold its Gerber Life Insurance unit to Western & Southern Financial Group for $1.55 billion in cash. It also sold its U.S. confectionery business -- which includes Butterfinger and Baby Ruth candy bars -- to Italian candy-maker Ferrero International SA for $2.8 billion in cash.

Meanwhile, it has beefed up its coffee business. One year ago it bought the rights to market and sell Starbucks coffee and tea products in grocery and retail stores for more than $7 billion. In 2017, Nestlé bought a majority stake in U.S. premium coffee chain Blue Bottle.

In late 2017 it bought Canadian vitamin maker Atrium Innovations Inc., for $2.3 billion.

"Nestlé is well on track in successfully reshuffling its portfolio, " the Vontobel analysts said.

--Anthony Shevlin in Barcelona contributed to this article.

Write to Brian Blackstone at brian.blackstone@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
LONDON COFFEE -1.07% 1765 End-of-day quote.0.00%
LONDON SUGAR 0.27% 334.1 End-of-day quote.0.03%
NESTLÉ -1.13% 101.08 Delayed Quote.28.12%
NESTLÉ -1.16% 90.34 Delayed Quote.28.37%
NEW YORK COCOA 1.16% 2529 End-of-day quote.4.55%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NESTLÉ
06/14Chicken producer Perdue enters crowded plant-based meat market
06/14NESTLE : Nestlé launches new product for lactating mothers to support breastfeed..
06/13Danone CFO says China's baby formula plan 'not a surprise'
06/12MCDONALD : No meat please! Nestle may extend plant-based burger partnerships
06/11NESTLE FOODS NIGERIA : Nestlé Nigeria restates commitment to addressing plastic ..
06/11NESTLE : Europe chief sees little impact from hard Brexit
06/11NESTLE : presentation 1Mb
06/10NESTLE : Companies pushed baby formula in Peru despite ban
06/08NESTLE FOODS NIGERIA : Nigeria cleans up Beach to commemorate World Ocean Day
06/06Beyond Meat's home in the meat aisle sparks food fight
More news
Financials (CHF)
Sales 2019 95 405 M
EBIT 2019 16 378 M
Net income 2019 11 335 M
Debt 2019 33 029 M
Yield 2019 2,59%
P/E ratio 2019 25,91
P/E ratio 2020 23,12
EV / Sales 2019 3,60x
EV / Sales 2020 3,45x
Capitalization 311 B
Duration : Period :
Nestlé Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 101  CHF
Spread / Average Target -0,22%
EPS Revisions
Ulf Mark Schneider Chief Executive Officer & Director
jeff hamilton President
Paul Bulcke Chairman
Magdi Batato Executive Vice President-Operations
François-Xavier Michel Marie Roger Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NESTLÉ28.37%312 792
NESTLÉ28.12%312 792
DANONE20.47%56 325
GENERAL MILLS36.06%30 323